About Immunostep
Immunostep is a Healthcare company based in Salamanca (Spain) founded in 2001. Flow cytometry reagents for diagnostics and clinical research are developed. Immunostep has raised $790.1 thousand across 1 funding round. Immunostep offers products and services including HeMoStep Kit, Exosome Isolation Columns, and Antibodies. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents.
Company details
Immunostep was established in 2001 as a spin-off from the University of Salamanca in Spain. Reagents and equipment for flow cytometry-based diagnostics and clinical research are produced by the company. The product range encompasses antibodies, isotype controls, recombinant proteins, apoptosis tools, diagnostic kits, and immunobead assays. Custom services, including generation, production, and manipulation of monoclonal and polyclonal antibodies, are offered from its base in Salamanca.
- Headquarters Salamanca, Spain
- SectorsHealthcare
- Email••••••••
- Website immunostep.com
- Social LinkedIn X Facebook YouTube
- Total Equity Funding$790.1K (USD)
in 1 rounds
- Latest Funding Round$790.1K (USD), Private Equity Round
Jul 2013
Products & Services of Immunostep
Immunostep offers a comprehensive portfolio of products and services, including HeMoStep Kit, Exosome Isolation Columns, and Antibodies.
Detects blood contamination in CSF for accurate diagnostics.
Tools for isolating exosomes from fluid samples.
Various antibodies for flow cytometry applications.
Apps and channels of Immunostep
its YouTube channel Immunostep has 27 subscribers and 17 videos.
Videos from Immunostep
The most watched videos on Immunostep's YouTube channel, Immunostep (27 subscribers). Click a video to play it here.
More on Immunostep.
Funding Insights of Immunostep
Immunostep has successfully raised a total of $790.1K through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $790.1 thousand completed in July 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $790,104
- Total Rounds 1
- Last Round Private Equity Round — $790,104
- First Round $790,104
(Jul 2013)
All 1 funding rounds of Immunostep with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2013 | $790,104 | Private Equity Round | – | – | – |
Timeline of Immunostep
2 dated milestones of Immunostep across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Immunostep is founded.
- Funding First funding round of $790K.
Web traffic of Immunostep
The website of Immunostep (immunostep.com) receives about 8.9K visits a month.
- Monthly visits8.9K
▲ 16% vs previous month
Websites whose visitors overlap most with Immunostep. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| eylabs.com | 100% | #5,913,034 | View details | ||
| seralab.co.uk | 100% | View details | |||
| innov-research.com | 74% | View details | |||
| antibodiesinc.com | 38% | 21K | #1,321,745 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Immunostep
Immunostep was founded in 2001 and raised its 1st funding round 12 years after it was founded.
Immunostep is headquartered in Salamanca, Spain. It is registered at Salamanca, Castile And Leon, Spain.
Immunostep is a funded company, having raised a total of $790.1K across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $790.1K, raised on Jul 2013.
Immunostep was established in 2001 as a spin-off from the University of Salamanca in Spain. Reagents and equipment for flow cytometry-based diagnostics and clinical research are produced by the company. The product range encompasses antibodies, isotype controls, recombinant proteins, apoptosis tools, diagnostic kits, and immunobead assays. Custom services, including generation, production, and manipulation of monoclonal and polyclonal antibodies, are offered from its base in Salamanca.
Immunostep offers HeMoStep Kit, Exosome Isolation Columns, and Antibodies.